Henry T Akinbi
Overview
Explore the profile of Henry T Akinbi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
729
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van Hoogdalem M, Tanaka R, Abduljalil K, Johnson T, Wexelblatt S, Akinbi H, et al.
Pharmaceutics
. 2024 Mar;
16(3).
PMID: 38543269
Buprenorphine readily crosses the placenta, and with greater prenatal exposure, neonatal opioid withdrawal syndrome (NOWS) likely grows more severe. Current dosing strategies can be further improved by tailoring doses to...
2.
Taleghani A, Isemann B, Rice W, Ward L, Wedig K, Akinbi H
Paediatr Neonatal Pain
. 2022 May;
1(2):33-38.
PMID: 35548374
We aimed to compare the outcomes of pharmacotherapy with either buprenorphine or methadone in infants treated for neonatal abstinence syndrome (NAS) secondary to intrauterine exposure to methadone. This is a...
3.
van Hoogdalem M, Wexelblatt S, Akinbi H, Vinks A, Mizuno T
Pharmacol Ther
. 2021 Nov;
234:108045.
PMID: 34813863
Physiologically-based pharmacokinetic (PBPK) modeling has emerged as a useful tool to study pharmacokinetics (PK) in special populations, such as pregnant women, fetuses, and newborns, where practical hurdles severely limit the...
4.
Rose S, Blunden C, Jarrett O, Kaplan K, Caravantes R, Akinbi H
J Pediatr
. 2021 Nov;
242:152-158.e1.
PMID: 34748741
Objective: To assess for possible missed hypothyroidism in infants of very low birth weight (VLBW) whose initial newborn screening (NBS) was within normal reference range. Study Design: We analyzed serum...
5.
van Hoogdalem M, Johnson T, McPhail B, Kamatkar S, Wexelblatt S, Ward L, et al.
Clin Pharmacol Ther
. 2021 Oct;
111(2):496-508.
PMID: 34679189
Neonatal opioid withdrawal syndrome (NOWS) is a major public health concern whose incidence has paralleled the opioid epidemic in the United States. Sublingual buprenorphine is an emerging treatment for NOWS,...
6.
van Hoogdalem M, McPhail B, Hahn D, Wexelblatt S, Akinbi H, Vinks A, et al.
Expert Opin Drug Metab Toxicol
. 2020 Oct;
17(1):87-103.
PMID: 33049155
Introduction: Neonatal opioid withdrawal syndrome (NOWS) often arises in infants born to mothers who used opioids during pregnancy. Morphine, methadone, and buprenorphine are the most common first-line treatments, whereas clonidine...
7.
Mizuno T, McPhail B, Kamatkar S, Wexelblatt S, Ward L, Christians U, et al.
Clin Pharmacokinet
. 2020 Sep;
60(2):249-259.
PMID: 32939690
Background And Objective: Buprenorphine has been shown to be effective in treating infants with neonatal opioid withdrawal syndrome. However, an evidence-based buprenorphine dosing strategy has not been established in the...
8.
Kuang Z, Bennett R, Lin J, Hao Y, Zhu L, Akinbi H, et al.
Virulence
. 2020 Aug;
11(1):1090-1107.
PMID: 32842850
The virulence behaviors of many Gram-negative bacterial pathogens are governed by quorum-sensing (QS), a hierarchical system of gene regulation that relies on population density by producing and detecting extracellular signaling...
9.
Mukhtar-Yola M, Audu L, Olaniyan O, Akinbi H, Dawodu A, Donovan E
BMJ Open Qual
. 2018 Sep;
7(3):e000231.
PMID: 30234170
The neonatal period is a critical time for survival of the child. A disproportionate amount of neonatal deaths occur in low-resource countries and are attributable to perinatal events, especially birth...
10.
Euteneuer J, Kamatkar S, Fukuda T, Vinks A, Akinbi H
J Clin Pharmacol
. 2018 Sep;
59(2):168-176.
PMID: 30204236
Evidence for dosing, efficacy, and safety of most medications used to treat neonates is sparse. Thus, dosing is usually derived by extrapolation from adult and pediatric pharmacologic data with scaling...